Skip to main content

Combined Hormonal Contraceptives & Venous Thromboembolism

Basic Details
Status
Ongoing
Last Updated
Tuesday, April 21, 2026
Original Posting Date
Purpose
Drug and Outcome Analysis
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Analytic Code Link(s) (1)
Use of Combined Hormonal Contraceptives or Progestin-only Contraceptives During 6-month Postpartum Period and the Risk of Venous Thromboembolism: A Propensity Score Matched Analysis
Result(s) (2)
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis
Related Publication(s) and/or Presentation(s) (1)
Presentation: Utilization of Hormonal Contraceptives During the Postpartum Period in the FDA Sentinel System